» Articles » PMID: 27138604

Quality of Life in Glaucoma: A Review of the Literature

Overview
Journal Adv Ther
Date 2016 May 4
PMID 27138604
Citations 94
Authors
Affiliations
Soon will be listed here.
Abstract

The ultimate goal of glaucoma management is the preservation of patients' visual function and quality of life (QoL). The disease itself as well as the medical or surgical treatment can have an enormous impact on a patient's QoL. Even the mere diagnosis of a chronic, irreversible, potentially blinding disorder can adversely affect the patient's sense of well-being and QoL by eliciting significant anxiety. Patients with primary open-angle glaucoma rarely present with visual symptoms, at least early in the course of the disease. A better understanding of patient-reported QoL can improve patient-physician interaction and enhance treatment adherence by customizing treatment options based on individual patient profile, thus optimizing long-term prognosis. These aspects are summarized and critically appraised in this article.

Citing Articles

Emerging perspectives in quality of life after trabeculectomy surgery.

Peixoto R, Stringa F, Cammack R, Liput J, King A Eye (Lond). 2025; .

PMID: 39922970 DOI: 10.1038/s41433-025-03636-1.


A Randomized Pilot Study of Four Dosing Schemes of Sublingual Methazolamide in Glaucoma Patients.

Tan N, Patnaik J, McWilliams S, Seibold L, Kahook M Clin Ophthalmol. 2024; 18:3893-3901.

PMID: 39726639 PMC: 11669721. DOI: 10.2147/OPTH.S496420.


Quality of life and associated factors among patients with glaucoma attending at Boru Meda General Hospital, Northeast Ethiopia.

Mohammed H, Kassaw A, Seid F, Ayele S Sci Rep. 2024; 14(1):28969.

PMID: 39578501 PMC: 11584743. DOI: 10.1038/s41598-024-77422-6.


Evidence in Practice: A Review of Real-Life Studies and Clinical Experience with the Preservative-Free Tafluprost (0.0015%) and Timolol (0.5%) Fixed-Dose Combination.

Hollo G Clin Ophthalmol. 2024; 18:3185-3196.

PMID: 39534090 PMC: 11556326. DOI: 10.2147/OPTH.S479852.


Asymmetric Glaucoma and Corresponding Hearing Impairment.

Meliante L, Coco G, Francavilla B, Bianchi M, Velletrani G, Di Girolamo S J Clin Med. 2024; 13(21).

PMID: 39518640 PMC: 11546083. DOI: 10.3390/jcm13216501.


References
1.
Rabin R, de Charro F . EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001; 33(5):337-43. DOI: 10.3109/07853890109002087. View

2.
Atkinson M, Stewart W, Fain J, Stewart J, Dhawan R, Mozaffari E . A new measure of patient satisfaction with ocular hypotensive medications: the Treatment Satisfaction Survey for Intraocular Pressure (TSS-IOP). Health Qual Life Outcomes. 2003; 1:67. PMC: 280705. DOI: 10.1186/1477-7525-1-67. View

3.
Odberg T, Jakobsen J, Hultgren S, Halseide R . The impact of glaucoma on the quality of life of patients in Norway. II. Patient response correlated to objective data. Acta Ophthalmol Scand. 2001; 79(2):121-4. DOI: 10.1034/j.1600-0420.2001.079002121.x. View

4.
Lee P . Outcomes and endpoints in glaucoma. J Glaucoma. 1996; 5(4):295-7. View

5.
Thomas S, Friedmann E, Kao C, Inguito P, Metcalf M, Kelley F . Quality of life and psychological status of patients with implantable cardioverter defibrillators. Am J Crit Care. 2006; 15(4):389-98. View